Drug ID: | NPD4756 |
Drug Name: | APE1 inhibitors (cancer/retinopathy), ApeX Therapeutics |
Molecular Formula: | C21H30O6 |
Canonical SMILES: | CCCCCCCCC/C(=CC1=C(C)C(=O)C(=C(C1=O)OC)OC)/C(=O)O |
Standard InCHI: | InChI=1S/C21H30O6/c1-5-6-7-8-9-10-11-12-15(21(24)25)13-16-14(2)17(22)19(26-3)20(27-4)18(16)23/h13H,5-12H2,1-4H3,(H,24,25)/b15-13+ |
Standard InCHIKey: | AALSSIXXBDPENJ-FYWRMAATSA-N |
Max Developmental Stage: | Discovery |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB008299 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 378.20 |
ALogP | -2.2083 |
MLogP | 3.11 |
XLogP | 4.866 |
HDA | 6 |
HBD | 1 |
Rotatable Bonds | 17 |
TPSA | 89.9 |
RO5 Violation | 1 |